Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study

Søren Friis, Aslak H. Poulsen, Henrik Toft Sørensen, Anne Tjønneland, Kim Overvad, Ulla Vogel, Joseph K. McLaughlin, William J. Blot, Jørgen H. Olsen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Abstract

    The optimal duration and dose of aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) in the potential prevention of colorectal cancer (CRC) have not been established. We examined this issue in the Danish Diet, Cancer, and Health Study.

    Self-reported NSAID use at entry (January 1995-May 1997) was updated through June 2006, using a nationwide prescription database. CRC incidence was ascertained from nationwide registers. Cox proportional hazards regression was used to compute confounder-adjusted incidence rate ratios (RRs) and 95% confidence intervals (CIs).

    From 51,053 cohort subjects, we identified 615 CRC cases during 1995-2006. Daily aspirin use at entry was associated with a decreased risk of CRC (RR, 0.73; 95% CI, 0.49-1.10). A similar risk reduction was seen among subjects with 10 or more prescriptions for aspirin or non-aspirin NSAIDs and five or more years of follow-up. Most aspirin prescriptions were for 75-150 mg aspirin tablets. Among non-aspirin NSAID users, only those with body mass index (BMI) above 25 showed risk reductions [RR, 0.69 (0.47-1.03) for 10 or more prescriptions].

    Long-term consistent use of aspirin or non-aspirin NSAIDs appears necessary to achieve a protective effect against CRC. Further studies of the effective dose of aspirin and the potential interaction between NSAID use and BMI are warranted.

    OriginalsprogEngelsk
    TidsskriftCancer Causes & Control
    Vol/bind20
    Udgave nummer5
    Sider (fra-til)731-740
    ISSN0957-5243
    DOI
    StatusUdgivet - 2009

    Citer dette

    Friis, S., Poulsen, A. H., Sørensen, H. T., Tjønneland, A., Overvad, K., Vogel, U., McLaughlin, J. K., Blot, W. J., & Olsen, J. H. (2009). Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study. Cancer Causes & Control, 20(5), 731-740. https://doi.org/10.1007/s10552-008-9286-7